The emergence of resistance to targeted cancer therapeutics.

The emergence of resistance to targeted cancer therapeutics.

Item
http://www.wikidata.org/entity/Q34837015
Focal adhesion-chromatin linkage controls tumor cell resistance to radio- and chemotherapySomatic variation and cancer: therapies lost in the mix.Anti-tumor activity of new artemisinin-chalcone hybrids.The application of tandem aza-wittig reaction to synthesize artemisinin-guanidine hybrids and their anti-tumor activity.Therapy's Shadow: A Short History of the Study of Resistance to Cancer Chemotherapy.Expression of 'drugable' tyrosine kinase receptors in malignant peripheral nerve sheath tumour: potential molecular therapeutic targets for a chemoresistant cancerThe subtle benefits of being promiscuous: adaptive evolution potentiated by enzyme promiscuity.Whole exome sequencing identifies mTOR and KEAP1 as potential targets for radiosensitization of HNSCC cells refractory to EGFR and β1 integrin inhibition.
P2860

The emergence of resistance to targeted cancer therapeutics.

Item
http://www.wikidata.org/entity/Q34837015
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The emergence of resistance to targeted cancer therapeutics.
@ast
The emergence of resistance to targeted cancer therapeutics.
@en
The emergence of resistance to targeted cancer therapeutics.
@nl
type
label
The emergence of resistance to targeted cancer therapeutics.
@ast
The emergence of resistance to targeted cancer therapeutics.
@en
The emergence of resistance to targeted cancer therapeutics.
@nl
prefLabel
The emergence of resistance to targeted cancer therapeutics.
@ast
The emergence of resistance to targeted cancer therapeutics.
@en
The emergence of resistance to targeted cancer therapeutics.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
The emergence of resistance to targeted cancer therapeutics.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698